Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tavilermide is a selective and partial agonist of TrkA or a nerve growth factor mimetic.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 6-8 weeks | $ 447.00 | |
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Tavilermide is a selective and partial agonist of TrkA or a nerve growth factor mimetic. |
In vitro | Tavilermide demonstrates activities similar to NGF (but does not bind to the p75NTR receptor) and can potentiate the effects of suboptimal concentrations of NGF. Tavilermide is a proteolytically stable, cyclic peptidomimetic that has been shown to be a partial TrkA receptor agonist [1]. |
Synonyms | MIM-D3 |
Molecular Weight | 580.54 |
Formula | C24H32N6O11 |
CAS No. | 263251-78-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 5 mg/mL (8.61 mM), when pH is adjusted to 3-4 with HCl.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tavilermide 263251-78-1 Tyrosine Kinase/Adaptors Trk receptor MIM-D3 inhibitor inhibit